Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Times Interest Earned (2021 - 2025)

Historic Times Interest Earned for Verrica Pharmaceuticals (VRCA) over the last 5 years, with Q3 2025 value amounting to $0.78.

  • Verrica Pharmaceuticals' Times Interest Earned rose 10891.67% to $0.78 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.87, marking a year-over-year increase of 7745.19%. This contributed to the annual value of -$7.0 for FY2024, which is 5780.24% up from last year.
  • According to the latest figures from Q3 2025, Verrica Pharmaceuticals' Times Interest Earned is $0.78, which was up 10891.67% from $0.71 recorded in Q2 2025.
  • Over the past 5 years, Verrica Pharmaceuticals' Times Interest Earned peaked at $17.88 during Q3 2022, and registered a low of -$14.43 during Q3 2023.
  • Over the past 5 years, Verrica Pharmaceuticals' median Times Interest Earned value was -$7.28 (recorded in 2022), while the average stood at -$5.04.
  • Over the last 5 years, Verrica Pharmaceuticals' Times Interest Earned had its largest YoY gain of 26588.36% in 2022, and its largest YoY loss of 1183364.14% in 2022.
  • Quarter analysis of 5 years shows Verrica Pharmaceuticals' Times Interest Earned stood at -$7.72 in 2021, then soared by 331.53% to $17.88 in 2022, then crashed by 156.15% to -$10.04 in 2023, then skyrocketed by 51.61% to -$4.86 in 2024, then surged by 116.0% to $0.78 in 2025.
  • Its last three reported values are $0.78 in Q3 2025, $0.71 for Q2 2025, and -$3.69 during Q1 2025.